Protara Therapeutics, Inc. (TARA)
NASDAQ: TARA · Real-Time Price · USD
2.680
+0.090 (3.47%)
Nov 5, 2024, 1:16 PM EST - Market open
Protara Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Net Income | -40.69 | -40.42 | -65.95 | -47.25 | -33.98 | -7.83 | |
Depreciation & Amortization | 0.35 | 0.34 | 0.25 | 0.12 | 0.2 | 0.02 | |
Asset Writedown & Restructuring Costs | - | - | 29.52 | - | - | - | |
Loss (Gain) From Sale of Investments | -0.32 | -0.44 | 1.14 | 1.74 | - | - | |
Stock-Based Compensation | 5.19 | 6.09 | 6.69 | 10.36 | 9.75 | 0.42 | |
Other Operating Activities | 0.83 | 1.01 | 1.37 | 1.05 | - | - | |
Change in Accounts Payable | -0.47 | 0.85 | 0.63 | 0.04 | 0.2 | 0.37 | |
Change in Other Net Operating Assets | 1.78 | -4.99 | -0.09 | -0.56 | 0.43 | 2.01 | |
Operating Cash Flow | -33.33 | -37.56 | -26.46 | -34.5 | -23.41 | -5.01 | |
Capital Expenditures | -0.09 | -0.05 | -0.12 | -0.6 | -0.88 | -0.48 | |
Cash Acquisitions | - | - | - | - | 3.72 | - | |
Investment in Securities | 47.03 | 53.15 | 15.07 | -97.6 | - | - | |
Investing Cash Flow | 46.94 | 53.11 | 14.95 | -98.19 | 2.84 | -0.48 | |
Short-Term Debt Repaid | - | - | - | - | -1.67 | - | |
Total Debt Repaid | - | - | - | - | -1.67 | - | |
Net Debt Issued (Repaid) | - | - | - | - | -1.67 | - | |
Issuance of Common Stock | 0.14 | - | - | - | 86.51 | 0.5 | |
Repurchase of Common Stock | -0.11 | -0.09 | -0.09 | -0.23 | - | - | |
Other Financing Activities | 41.96 | - | - | - | 12.95 | - | |
Financing Cash Flow | 41.99 | -0.09 | -0.09 | -0.23 | 189.4 | 0.5 | |
Net Cash Flow | 55.6 | 15.46 | -11.6 | -132.92 | 168.83 | -4.99 | |
Free Cash Flow | -33.42 | -37.6 | -26.58 | -35.1 | -24.29 | -5.49 | |
Free Cash Flow Per Share | -2.41 | -3.32 | -2.36 | -3.12 | -3.36 | -2.13 | |
Cash Interest Paid | - | - | - | - | 0.03 | - | |
Levered Free Cash Flow | -20.31 | -21.88 | -15.16 | -20.23 | -13.65 | -2.55 | |
Unlevered Free Cash Flow | -20.31 | -21.88 | -15.16 | -20.23 | -13.63 | -2.55 | |
Change in Net Working Capital | -1.9 | 1.01 | -1.49 | 0.43 | 1.16 | -2.38 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.